Medtronic’s MiniMed spin‑off has filed its IPO prospectus, proposing to sell 28 million shares at $25‑$28 each to raise roughly $742 million, valuing the company at about $7.44 billion. The NASDAQ listing will be led by Goldman Sachs, BofA Securities, Citigroup and Morgan Stanley, with pricing expected next week. MiniMed, a pioneer in wearable insulin pumps and continuous glucose monitors, generated $2.9 billion in FY 2025 revenue but posted a $196 million loss. Medtronic will continue to hold a controlling interest after the offering.
Generate Biomedicines, Inc. (GENB) launched a $400 million IPO on Feb 23, 2026, offering 25 million shares at $15‑$17 each on NASDAQ. At the midpoint price of $16, the company would be valued at roughly $2.04 billion. The proceeds are earmarked for two Phase 3 trials...
Rank One Computing (ROC) upsized its IPO to 4 million shares and priced the offering at the top of its range, $6 per share, raising roughly $24 million and valuing the company at about $114 million. The Nasdaq debut saw the stock open...
Rank One Computing (ROC) priced its Nasdaq IPO at $6.00 per share, increasing the offering to 4 million shares and raising $24 million on Feb 19, 2026. The Benchmark Company acted as sole book‑runner, and the shares opened at $6.30 on Feb 20, 2026, marking a...
Organic baby‑food maker Once Upon a Farm, PBC priced its IPO at $18 per share on Feb. 5, 2026, selling nearly 11 million shares to raise $197.95 million. The offering was led by Goldman Sachs and J.P. Morgan, with BofA Securities, William Blair, Barclays, Evercore ISI,...